Reduced Expression of Galectin-9 Contributes to a Poor Outcome in Colon Cancer by Inhibiting NK Cell Chemotaxis Partially through the Rho/ROCK1 Signaling Pathway.
Wang Y, Sun J, Ma C, Gao W, Song B, Xue H, Chen W, Chen X, Zhang Y, Shao Q, Wang Q, Zhao L, Liu J, Wang X, Wang H, Zhang Y, Yang M, Qu X.
Wang Y, et al. Among authors: wang x, wang h, wang q.
PLoS One. 2016 Mar 30;11(3):e0152599. doi: 10.1371/journal.pone.0152599. eCollection 2016.
PLoS One. 2016.
PMID: 27028892
Free PMC article.
Clinical Trial.